Showing results (1-10 of 369) with videos related to
Sort By:
Pageof 37
European Neurology|January 1, 1986
Apolipoproteins AI, AII and HDL phospholipids but not APO-B are risk indicators for occlusive cerebrovascular diseaseG M Kostner, E Marth, K P Pfeiffer, et al.Archives of Disease in Childhood|September 1, 1991
Lipoprotein (a) concentrations as risk indicators for atherosclerosisG M Kostner, A Czinner, K H Pfeiffer, et al.Wiener Medizinische Wochenschrift (1946)|September 30, 1984
[Lipoprotein Lp(a) as a risk factor for heart infarct--a family study]G Klein, P Brugger, W Kullich, et al.Annals of Nutrition & Metabolism|January 1, 1982
Serum concentrations of Lp(a) and other lipoprotein parameters in heavy alcohol consumersE Marth, G Cazzolato, G Bittolo Bon, et al.Arteriosclerosis (Dallas, Tex.)|July 1, 1988
Lipoprotein Lp(a). A risk factor for myocardial infarctionG Hoefler, F Harnoncourt, E Paschke, et al.Advances in Lipid Research|January 1, 1983
Apolipoproteins and lipoproteins of human plasma: significance in health and in diseaseG M KostnerCardiology|January 1, 1991
Lipoprotein metabolism and atherogenesis: implications for therapyG M KostnerWiener Medizinische Wochenschrift (1946)|January 1, 1994
[MED-PED: make early diagnosis--prevent early death]G M KostnerWiener Medizinische Wochenschrift (1946)|July 17, 1999
[Pharmacology of HMG CoA reductase inhibitors (statins)]G M KostnerPageof 37